UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number: 001-42453
Park Ha Biological Technology Co., Ltd.
901 & 901-2, Building C
Phase 2, Wuxi International Life Science Innovation
Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Information Contained in this Form 6-K Report
Submission of Membership
Application to Personal Care Products Council
On July 1, 2026, Park
Ha Biological Technology Co., Ltd. (the “Registrant”) announced that it had formally filed a complete membership application
with the Personal Care Products Council (PCPC), a preeminent trade association for the personal care industry in North America.
The submission encompasses
all requisite corporate qualifications, raw material compliance documentation, and product safety materials, all of which are currently
under review. This application marks a pivotal step in establishing the Company’s compliance framework for the North American market and
facilitating its planned entry into Amazon’s North America marketplace.
Founded in 1894, PCPC
serves as the primary architect of key regulatory frameworks, including MoCRA, FDA cosmetic standards, and the INCI ingredient naming
system, and represents over 90% of major U.S. cosmetics and skincare companies.
The PCPC membership application has been advanced in parallel with the Company’s cooperation with Amazon North America, supporting
the establishment of a comprehensive compliance framework for its international expansion.
The foregoing description
is qualified in its entirety by the press release attached as Exhibit 99.1 to this Form 6-K.
Issuance of Press
Release
On July 1, 2026, the
Registrant issued a press release announcing the event described above. A copy of the press release is attached hereto as Exhibit
99.1.
Forward Looking Statements
Matters discussed in
this report may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying assumptions and other statements that are not historical facts. Words such as
“believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,”
“plans,” “will,” “would,” “should,” “could,” “may” or similar
expressions identify forward-looking statements. The forward-looking statements in this report are based upon various assumptions. Although
the Registrant believes that these assumptions were reasonable when made, they are inherently subject to significant uncertainties and
contingencies that are difficult or impossible to predict and are beyond the Registrant’s control, the Registrant cannot assure
you that it will achieve or accomplish these expectations. Actual results may differ materially from those anticipated. The Registrant
undertakes no obligation to update or revise any forward-looking statements, except as required by law.
EXHIBIT INDEX
The following exhibit is being filed herewith:
| Exhibit No. |
|
Description |
| 99.1 |
|
Press release of the Company dated July 1, 2026 |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Park Ha Biological Technology Co., Ltd. |
| |
|
|
| Date: July 1, 2026 |
By: |
/s/ Xiaoqiu Zhang |
| |
Name: |
Xiaoqiu Zhang |
| |
Title: |
Chief Executive Officer, Chairperson of the Board of Directors |
Exhibit 99.1
Park Ha Biological Technology Co., Ltd. Announces
Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic
Milestone in its Expansion into Amazon North America
Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) – Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological”
or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council
(PCPC). The submission encompasses all requisite corporate qualifications, raw material compliance documentation, and product safety materials,
all of which are currently under review. This application marks a pivotal step in establishing the Company’s comprehensive compliance
framework for the North American market, facilitating its planned entry into Amazon’s North America marketplace, and securing access
to the technical, regulatory, and industry resources essential for success in the U.S. personal care sector.
Founded in 1894, PCPC is the preeminent trade
association for the personal care industry in North America, serving as the primary architect and authoritative interpreter of key regulatory
frameworks, including the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), Food and Drug Administration (FDA) cosmetic standards,
and the International Nomenclature of Cosmetic Ingredients (INCI) ingredient naming system. PCPC represents over 90% of major U.S. cosmetics
and skincare companies, with global industry leaders such as Estée Lauder, L’Oréal, Procter & Gamble, Unilever,
Beiersdorf, and Kiehl’s among its long-standing members. PCPC’s industry recognition and compliance endorsement carry substantial
weight, with membership status widely regarded as a definitive benchmark for brands seeking compliant access to North American e-commerce
and retail channels.
As a technology-driven skincare brand committed to comprehensive expansion in the North American market, Park Ha Biological has proactively
secured industry access qualifications, meticulously compiled required application materials, and systematically advanced the membership
verification process.
The head of the Brand Overseas Division of the
Company emphasized that North America’s stringent regulatory landscape demands proactive engagement, and joining PCPC is a cornerstone
of the Company’s long-term globalization strategy. Through PCPC’s extensive global membership network, Park Ha Biological
aims to forge connections with established North American brands, leading contract manufacturers, raw material suppliers, and testing
laboratories, thereby building a resilient overseas supply chain to support both its upcoming Amazon online operations and future offline
retail expansion.
The PCPC membership application has been advanced in parallel with the Company’s cooperation with Amazon North America, supporting
the establishment of a comprehensive and robust compliance framework for its international expansion.
About Park Ha Biological Technology Co., Ltd.
Established in 2016, Park Ha Biological Technology
Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare product sales and franchise promotion under the
proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence
of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China.
As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales
beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company’s
website: http://ir.parkha.cn/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking
statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current
expectations and projections about future events that the Company believes may affect its financial condition, results of operations,
business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,”
“believes,” “hopes,” “expects, “anticipates,” “estimates,” “projects,”
“intends,” “plans,” “will,” “would,” “should,” “could,” “may”
or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking
statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you
that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from
the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration
statement and other filings with the SEC.
For more information, please contact:
Park Ha Biological Technology Co., Ltd.
901
& 901-2, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
ir_parkha@163.com